This state of the art research and development laboratory is a top-tier Contract Research Organization (CRO) with a signed $10M annual contract starting in 2025, with the option of annual renewal after that. This lab will provide advanced services in analytical chemistry, microbiology testing, product development support, and clinical research studies, and consulting services for the pharmaceutical, medical devices, and biotechnology industries. They have two additional signed contracts in 2025 for $750K for medical device testing, and several other projects that are under negotiations. The Owner is open to creative deal structures and can stay on to help execute and manage these projects. This is a business that cannot fail, because of multiple streams of income. They are a GLP/GMP FDA-registered facility with DEA License, CLIA Certification, and ISO 17025 Certification, emphasizing strict quality standards. As a strategic partner, they guide pharmaceutical innovations from concept to market, ensuring success through their commitment to scientific excellence and regulatory compliance. Specializing in pharmaceutical R&D, analytical chemistry testing, and quality compliance consulting, The Owner is open to creative deal structures and can stay on to coordinate business activities and bring new projects.